This site is intended for healthcare professionals only
LoginRegister
Gland Pharma profit rises 12 percent to Rs 184 crore in Q2Gland Pharma bags USFDA nod for Cangrelor for Injection
CDSCO Cancels Registration Certificate of G3 Medical Systems for Import of Allergan CosmeticsCDSCO Cancels Cosmetic Import Registration of Indian Agent for Proteos Biotech
Cybercriminals Trick Dr Reddys Finance Team, Divert Rs 2.16 Crore PaymentDr Reddy's Labs gets USFDA EIR for Miryalaguda facility
Boehringer Hernexeos gets USFDA accelerated approval for previously treated patients with HER2-mutant advanced NSCLCBoehringer Hernexeos gets USFDA accelerated approval for previously treated patients with...
Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UKShilpa Medicare gets CDSCO green light for Non-Alcoholic Fatty Liver Disease treatment
Zydus Amplitude receives CE mark for robotic surgical system AndyUSFDA approves Zydus Lifesciences chronic idiopathic constipation drug Prucalopride
Lupin plans to build new pharma manufacturing plant in Coral SpringsLupin unveils Glucagon for Injection for severe hypoglycemia in patients with diabetes mellitus in...
Alembic Pharma gets USFDA nod for angina drug Diltiazem HydrochlorideZydus bags USFDA nod for chronic stable angina drug Diltiazem Hydrochloride
DCGI Orders Nationwide GMP Inspection Drive to Enforce Revised Schedule MNo More Physical WHO-GMP Certificate Applications After August 15: DCGI Alerts Pharma Firms
DoP Shortlists Patented, Unlaunched Drugs for Global Tender Exemption, See Full ListNo Life-Saving Drug Category In India, Govt Clarifies as 930 Medicines Remain Under Price Control
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataCDSCO Panel Accepts Glenmark's Apremilast Trial Report, Seeks 2-Year PSUR Data
Sun Pharma Gets CDSCO Panel Nod to Conduct Active Post-Marketing Study for Antacid Combination TabletSun Pharma Gets CDSCO Panel Nod For Alfuzosin-Tadalafil FDC Post-Marketing Study
X